Medacta
Medacta International SA, headquartered in Switzerland (CH), is a leading player in the global medical device industry, specialising in orthopaedic and spinal surgery solutions. Founded in 1999, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Medacta is renowned for its innovative products, such as the M.O.R.E. (Medacta Orthopaedic Research and Education) programme, which enhances surgical techniques and patient outcomes. The company’s commitment to advanced technology and minimally invasive procedures sets it apart in the competitive landscape. With a focus on quality and precision, Medacta has achieved significant milestones, including numerous regulatory approvals and a growing portfolio of patented technologies. Its dedication to improving surgical performance and patient care solidifies its position as a trusted name in orthopaedics and spinal surgery.
DitchCarbon Score
How does Medacta's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medacta's score of 8 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medacta's reported carbon emissions
In 2023, Medacta reported total carbon emissions of approximately 1,458,000 kg CO2e, which includes 949,000 kg CO2e from Scope 1 and 509,000 kg CO2e from Scope 2 emissions. The company has shown a commitment to reducing its carbon footprint over the years, with a notable decrease in Scope 1 emissions from 500,000 kg CO2e in 2017 to 393,000 kg CO2e in 2021, and further to 353,000 kg CO2e in 2022. Despite these reductions, there are currently no specific reduction targets or climate pledges disclosed by Medacta. The company continues to focus on its emissions management, particularly in Scope 1 and Scope 2 categories, while also addressing its overall environmental impact. Medacta's headquarters is located in Switzerland (CH), and it operates with a global revenue of approximately USD 546,763,331 in 2023.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 500,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | - | - | - | - | - | - | 000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medacta is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
